What is the global market size of Chemiluminescence Immunoassay Analyzers Market?

Global Chemiluminescence Immunoassay Analyzers Market size was valued at USD 5.04 billion in 2021 and is poised to grow from USD 5.41 billion in 2022 to USD 9.66 billion by 2030, growing at a CAGR of 7.5% in the forecast period (2023-2030).

Chemiluminescence Immunoassay Analyzers Market Size, Share, Growth Analysis, By Product(Fully Automated Chemiluminescence Immunoassay Analyzers and Semi-Automated Chemiluminescence Immunoassay Analyzers), By Application(Infectious Disease Testing, Endocrine System Testing, Cardiac Marker Testing, Oncology Testing), By End User(Hospitals, Diagnostic Laboratories, Research Institutes, and Point-of-Care Testing), By Region - Industry Forecast 2024-2031

Report ID: SQMIG35H2242 | Region: Global | Published Date: April, 2024
Pages: 219 | Tables: 93 | Figures: 76

Chemiluminescence Immunoassay Analyzers Market News

In January 2024, in a landmark event for Indian healthcare technology, Kochi-based Agappe unveiled its first indigenously manufactured HX series haematology equipment and the AE-powered Immunology CLIA (Chemiluminescence Immunoassay) analyser, the Mispa i200, marking a new era in diagnostics and patient care.
In January 2024, Fujirebio Holdings, Inc. and Agappe Diagnostics Ltd announced that they have entered into an agreement of Contract Development and Manufacturing Organization (CDMO) partnership for Cartridge based CLIA system reagents manufacturing project for the immunology equipment Mispa i60 and Mispa i121.

Chemiluminescence Immunoassay Analyzers Market Report Snapshots

License Type Top market research company in USA

File Type

$5,300

BUY NOW GET FREE SAMPLE

Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Chemiluminescence Immunoassay Analyzers Market size was valued at USD 5.41 billion in 2022 and is poised to grow from USD 5.82 billion in 2023 to USD 10.37 billion by 2031, growing at a CAGR of 7.5% in the forecast period (2024-2031).

There exists fierce competition in the chemiluminescence immunoassays analyzers market as different players seek for market dominance and technological leadership. The market is vibrant owing to the participation of key players such as prominent branded manufacturers and entry newcomers in the field. Companies take into account constant innovations, product development, and cooperative work with other players in order to prevail over each other. In the market, there is a wide range of chemiluminescence immunoassay analyzers that are designed differently to cater for various needs of the diagnostic laboratories and health care institutions. 'Roche Diagnostics', 'Abbott', 'Siemens Healthcare', 'Ortho Clinical Diagnostics', 'Beckman Coulter', 'Danaher (Beckman Coulter Life Sciences)', 'Johnson & Johnson (Ortho-Clinical Diagnostics)', 'DiaSorin', 'Luminex Corporation', 'Tosoh Bioscience', 'Snibe Diagnostics', 'Shenzhen Mindray Bio-Medical Electronics Co., Ltd.', 'Sysmex Corporation', 'Hytest Ltd.', 'Bio-Rad Laboratories, Inc.', 'PerkinElmer, Inc.', 'ARCHITECT Diagnostics, Inc.', 'Euroimmun Medizinische Labordiagnostika AG', 'Mesan Pharma', 'Abbott Point-of-Care Inc.'

Because of this prevalence of infectious and chronic diseases, more sophisticated instruments are required for reliable and instant diagnosis. Some of those famous brands are chemiluminescence immunoassay analyzers that are commonly used in different diagnostics laboratories. The world’s focus on early detection of disease and preventive measures also helps increase the demand for these analyzers. It is the case because technological developments are of great importance and frequent improvements increase the level, accuracy, and so on.

Automated integration of artificial intelligence (AI) in these analysers increases laboratory turnaround time and diagnostic interpretations. Besides, it facilitates tests’ administration as well as cutting down on time taken for results and increases in precision. Moreover, there is an increased interest in widening the field of use of such devices for cancer testing, screenings for microbial infections and hormone diagnostic studies. In addition, manufacturers are focusing on designing more friendly and portable analyzers aimed at addressing the growing market of PoC testing and remote diagnostics.

The region that probably will control the market is North America. It can be credited to the existing strong healthcare system, high medical expenditure, and great emphasis placed on technology enhanced diagnostics. This region has a considerable presence of main stakeholders and a number of research organisations, playing a vital role in adoption of sophisticated diagnostic technologies that make this area a leader.

Feedback From Our Clients

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

Chemiluminescence Immunoassay Analyzers Market News

Chemiluminescence Immunoassay Analyzers Market Report Snapshots

Want to customize this report?

FAQs

What is the market size of Chemiluminescence Immunoassay Analyzers Market?

Who are the key vendors in the Chemiluminescence Immunoassay Analyzers Market?

What is the key driver of Chemiluminescence Immunoassay Analyzers Market?

What is the key market trend for Chemiluminescence Immunoassay Analyzers Market?

Which region accounted for the largest share in Chemiluminescence Immunoassay Analyzers Market?

Request Free Customization

Related Reports

Feedback From Our Clients

$5,300